Nasal challenges with recombinant derivatives of the major birch pollen allergen Bet v 1 induce fewer symptoms and lower mediator release than rBet v 1 wild-type in patients with allergic rhinitis. (Q40628222)

From Wikidata

Jump to navigation Jump to search

scientific article published on October 2002

Language	Label	Description	Also known as
English	Nasal challenges with recombinant derivatives of the major birch pollen allergen Bet v 1 induce fewer symptoms and lower mediator release than rBet v 1 wild-type in patients with allergic rhinitis.	scientific article published on October 2002

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12372124%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

Nasal challenges with recombinant derivatives of the major birch pollen allergen Bet v 1 induce fewer symptoms and lower mediator release than rBet v 1 wild-type in patients with allergic rhinitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12372124%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

0 references

Marianne van Hage

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12372124%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12372124%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

author name string

E Johansson

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12372124%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

A Roquet

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12372124%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

C Peterson

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12372124%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

M Andersson

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12372124%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

L Greiff

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12372124%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

R Valenta

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12372124%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

R Grönneberg

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12372124%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

publication date

1 October 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12372124%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

Clinical & Experimental Allergy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12372124%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

32

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12372124%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12372124%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

1448-1453

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12372124%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

Role of interleukin 10 in specific immunotherapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2002.01495.X

21 January 2018

Recombinant allergens for diagnosis and therapy of allergic disease.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2002.01495.X

21 January 2018

Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2002.01495.X

21 January 2018

Intranasal treatment with a recombinant hypoallergenic derivative of the major birch pollen allergen Bet v 1 prevents allergic sensitization and airway inflammation in mice.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2002.01495.X

21 January 2018

High-level expression and purification of the major birch pollen allergen, Bet v 1.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2002.01495.X

21 January 2018

Nasal Secretions and Exudations: Collection and Approaches to Analysis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2002.01495.X

21 January 2018

Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2002.01495.X

21 January 2018

Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2002.01495.X

21 January 2018

Oral tolerance in disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2002.01495.X

21 January 2018

Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2002.01495.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2002.01495.X

21 January 2018

Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2002.01495.X

21 January 2018

Comparison of inflammatory responses to genetically engineered hypoallergenic derivatives of the major birch pollen allergen Bet v 1 and to recombinant Bet v 1 wild type in skin chamber fluids collected from birch pollen–allergic patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2002.01495.X

21 January 2018

Immunologic changes associated with allergen immunotherapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2002.01495.X

21 January 2018

Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: results obtained with a mix of two recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2002.01495.X

21 January 2018

Comparison of genetically engineered hypoallergenic rBet v 1 derivatives with rBet v 1 wild-type by skin prick and intradermal testing: results obtained in a French population

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2002.01495.X

21 January 2018

Loratadine reduces allergen-induced mucosal output of alpha 2-macroglobulin and tryptase in allergic rhinitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2002.01495.X

21 January 2018

Allergen-induced inflammation in the nose: a comparison of acute and repeated low-dose allergen exposure

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2002.01495.X

21 January 2018

Piecemeal degranulation of peripheral blood eosinophils: a study of allergic subjects during and out of the pollen season

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2002.01495.X

21 January 2018

T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2002.01495.X

21 January 2018

Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in atopic allergic asthmatic subjects

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2002.01495.X

21 January 2018

Identifiers

10.1046/J.1365-2745.2002.01495.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12372124%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12372124%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40628222&oldid=2050624567"